M.A. Viviani

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

Olle Ringdén, F. Meunier, J Tollemar et al. · Journal of Antimicrobial Chemotherapy · 1991 · 281 citations

New targets and delivery systems for antifungal therapy

Thomas J. Walsh, M.A. Viviani, Eduardo Arathoon et al. · Medical Mycology · 2000 · 160 citations · Full text

New Delivery Systems, New Targets, Antifungal Agent +9

Experience with Itraconazole in Deep Mycoses in Northern Italy. Erfahrungen mit Itraconazol bei tieflokalisierten Mykosen in Norditalien

M.A. Viviani, Anna Maria Tortorano, R. Woenstenborghs et al. · Mycoses · 1987 · 45 citations

Diagnostic Mycology, January 1985, Northern Italy +19

Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature

Beniamina Gallelli, M.A. Viviani, Manuela Nebuloni et al. · Journal of Nephrology · 2006 · 35 citations

Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient.

E. Cofrancesco, Carla Boschetti, M.A. Viviani et al. · PubMed · 1992 · 30 citations

Diagnostic Mycology, Antifungal Agent, Health Sciences +15